REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Endomedium + OOO (Russia)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Endomedium + OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Endomedium + OOO is an enterprise based in Russia. Its main office is in Kazan. The company operates in the Electromedical and Electrotherapeutic Apparatus Manufacturing sector. It was first established on November 14, 2002. The latest financial highlights indicate a net sales revenue increase of 20.38% in 2023. During that time, Endomedium + OOO’s total assets grew by 50.6%. In 2023, Endomedium + OOO’s net profit margin decreased by 1.71%.

Headquarters
Yamasheva, 36, 401
Kazan; Tatarstan Republic; Postal Code: 420044

Contact Details: Purchase the Endomedium + OOO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Endomedium + OOO report to view the information.
Registered Capital:
Purchase the Endomedium + OOO report to view the information.
Incorporation Date:
November 14, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
42%
Purchase this report to view the information.
26.5%
Purchase this report to view the information.
21.5%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Endomedium + OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
20.38%▲
Total operating revenue
20.38%▲
Operating profit (EBIT)
3.16%▲
Net Profit (Loss) for the Period
7.57%▲
Total assets
50.6%▲
Total equity
84.07%▲
Operating Profit Margin (ROS)
-2.7%▼
Net Profit Margin
-1.71%▼
Return on Equity (ROE)
-32.49%▼
Quick Ratio
0.46%▲
Cash Ratio
-0.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo